Why this innovation?

Respiratory viral infections, allergies, and dry eyes are a source of frequent, recurrent, and often chronic health needs. They call for safe, effective, and well-tolerated solutions that are suitable for long-term use and a broad audience, including sensitive populations.

Carragelose® (iota-carrageenan) is a naturally occurring polymer that is extracted from red algae and acts as a protective physical barrier on mucous membranes. This non-pharmacological technique meets a growing market demand for prevention and relief solutions with no systemic mechanism of action.

→

A need for effective solutions against a broad spectrum of respiratory viruses.

→

A demand for non-specific alternatives to block viruses and allergens on mucous membrane surfaces.

→

A demand for safe, well-tolerated products, usable in children from one year old.

→

A need for solutions covering multiple indications (respiratory, allergic, ophthalmic) and the whole season.

→

High regulatory expectations for MDR-compliant medical devices.

The solution: what it changes

Carragelose

Carragelose forms a moisturizing protective layer on nasal, pharyngeal, or ocular mucous membranes. As well as preventing viruses and allergens from adhering to cells, this barrier factilitates their natural elimination and strengthens the resilience of mucous membranes.

This mechanical, non-specific action allows for repeated use, without resistance phenomena, while offering an excellent safety profile.

 

 

What makes it unique:

 

  • Clinically validated and patent-protected
  • Favorable safety profile – can be used in children over one year old
  • Non-specific blocker against various external influences, such as viruses or allergens
  • Versatile product range covering the entire season
  • Carragelose products are certified as medical devices and are on track to be MDR compliant

Benefits

Risques infections

For patients

Respiratory viral infections

  • Non-specifically blocks respiratory viruses responsible
    for the common cold
  • Clinically validated
  • Range of seven products marketed for the nose and throat

Ophthalmology

  • Moisturizing eye drops
  • Dry eye relief
  • Antiviral properties: promising candidate for the treatment of adenoviral keratoconjunctivitis

Allergies

    • Blocks allergens on mucous membrane surfaces.
    • Effective reduction of nasal allergic symptoms.
    • Decongestant in combination with sorbitol.
Spray - multidose - comprimé

For manufacturing

  • Controlled aseptic processes.
  • Protected industrial know-how.
  • Preservative-free formulations.
  • Product platform adaptable to: nasal sprays (single and multi-dose), throat sprays, lozenges, ophthalmic drops.
  • Adaptability to market needs and partner portfolios.

Got questions? - Consult our Carragelose FAQ

Yes. Our out-licensing portfolio includes ocular lubricants, saline solutions, multi-dose products (with or without preservatives), and Eyeleen® (Carragelose®) for dry eye, to accelerate market access.